Showing results (3061-3070 of 5,673) with videos related to

Sort By:
Pageof 568
Lupus|May 20, 2025
Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of AmericaGabriel Contreras, Javier Pagan, Tali Elfassy, et al.
Lupus|May 16, 2025
Progressive repigmentation of hypopigmented lesions in discoid lupus erythematosus with anifrolumab: A report of two casesMargot Hulin, Agathe Le Seac'h, Léa Jaume, et al.
Lupus|February 12, 2026
Concurrent thalamic and cerebellar involvement in pediatric neuropsychiatric lupus: Expanding the radiologic spectrumJacob Anderson, Sareh Hosseinpour, Zahra Rezaei, et al.
Lupus|February 5, 2026
Dichotomous pathogenesis drives therapeutic choice: A case report and review of literature differentiating glucocorticoid-induced from disease activity-associated central serous chorioretinopathy in lupus nephritisYuyan Han, Lulu Huang, Mengni Yang, et al.
Lupus|January 23, 2026
Lupus nephritis outcomes in Aotearoa New Zealand, a retrospective case seriesJames Bowman, Douglas White, Chunhuan Lao, et al.
Lupus|January 23, 2026
Iron deficiency improves imiquimod-induced lupus-like disease by regulating the Th17/Treg balance and Nrf2/HO-1/GPX4 signaling pathwayYapeng Wang, Xinyue Gao, Zexuan Wu, et al.
Lupus|March 24, 2025
Association between extracellular vesicles (EVs) and thrombosis in antiphospholipid syndromeBruna Cardoso Jacintho-Robison, Jose Diogo Oliveira, Lucas Matheus Bispo Césped, et al.
Lupus|March 21, 2025
Budd Chiari syndrome associated with antiphospholipid syndrome: Clinical characteristics and prognosis of 17 patients from single centerÖmer Uludağ, Akın Işık, Ege Sinan Torun, et al.
Lupus|March 25, 2025
Progenitor cells and circulating endothelial cells are associated with disease activity and damage in systemic lupus erythematosus patientsGonzalo Silveira, Sabrina Ranero, Adriana Carlomagno, et al.
Lupus|March 19, 2025
Two-year treatment experience with BI 655064, an antagonistic anti-CD40 antibody, in patients with active lupus nephritis: An exploratory, phase II maintenance trialRichard Furie, Jürgen Steffgen, Nora Fagan, et al.
Pageof 568